Clinical trial

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

NCT00668343

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-04-01

PhasePHASE3

Study timeline

Study start (unknown)2005-04-01Date precision: month

Registry last updated2010-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Relapsing Remitting Multiple Sclerosisunresolved

Interventions

simvastatinDRUG · verified · RxNorm: simvastatin

placeboDRUG

Sponsors & collaborators

Tehran University of Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00668343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.